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Introduction 
Antidepressant medications, including ~cyclic 
antidepressants, monoamine oxidase inhibitors, 
lithium, and fluoxetine, generally have been found 
to suppress rapid eye movement (RFaM) sleep (yon 
Bardeleben et al. 1989, reviewed by Salem 1986), 
although several unusual antidepress~ts have 
been found to increase REM sleep (Wiegand et 
al. 1986; Di Peril et al. 1987; Soldatos et al. 1988; 
Monti 1989). Additional evidence that there may 
be a_n association between the antidepressant ef- 
fects of the medications and their REM sleep ef- 
fects include the following: (1)The extent to 
which amitrip~!ine (Kupfer et ai. 1976; Gillin et 
al. 1978; Kupfer et al. 1981) and clomipramine 
(H6chli et at: 1986) suppress REM sleep was 
found to ~redict eventual antidepressant re- 
sponse in depressed adults. Kupfer et al. (1979) 
extended these findings into depressed ctfildren 
,'xeated with hnipmmine. (2) Selective REM sleep 
deprivation improved depressive symptoms 
(Vogel et al. 1975). Eight of 9 subjects unre- 
speusive to selec~ve REM sleep depfivafian were 
also unre%-~onsive to imi_pramine. 
Characteristic sleep abnormalities found in 
depressed adults have not been consistently 
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demonswated in depressed adolescents. In a study 
consisting largely of outpatients, Goetz et al. 
(1987) ane Appeiboom-Fondu et al. (1988"~ noted 
only some sleep continuity disturbances and not 
the other characteristic abnormalides: reduced 
delta sleep, increased REM density during the 
early part of the night, and shortened REM la- 
tency (Kupfer et al. 1985). Eraslie et al. (1987) 
found all four abnomaalities in a sample of in- 
patients, as did Lahmeyer et al. (1983) i~ a 
sample of inpatients and outpatients. 
As yet, no studies have . . . . . . . .  - .... ':^ IOUilld tltldt ul~,~,~itt~.,
antidepressant therapy is more effective than 
placebo in the .treatment of adolescent depres- 
sion (Kramer and Feiguine 1981; Ryan et al. 
1986). This raises the question of whether or not 
tricyclic antidepressant medications cause changes 
in ~E.M sleep parameters in adolescents similar 
to those caused in adults. REM sleep changes re- 
ported in depressed adults on tficyclic antide- 
pressams include increased REM latency and de- 
creased REM t~me, REM activity, and number 
of IL~M refiodg ej~,,'re~ et al. !988; Htch!i et at.. 
|980: Kupfer et al. 1981). We are not aware of 
studies on the effects of these medications on sleep 
in depressed adolescents. The present study er- 
amined the acute effects of imipramine on elec- 
troencephalogram (EEG)-monitored sleep in ad- 
olescents with major depressive disorder (MDD). 
Methods  
The ~ubjects were i0 inpatients admitted to the 
Urfiversi~ ~f Michigan Medical Center Ado- 
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lescent Psychiatry Unit, a 14-bed clinical re- 
search unit. Informed consent was obtained. The 
sample included 6 girls and 4 boys, with a mean 
age of 15.1 years and an age range of 13-17 
years. The diagnosis of primary imipolar MDD 
was made by an attending child psychiatrist ac- 
cording to Research Diagnostic Criteria (Spitzer 
et al. 1978), using information from a multi- 
disciplinary evaluation and a semistructured in- 
tet~ciew with the Sc!hedule for Affective D:.sor- 
ders and Schizophrenia (Endicott and Spitzer 
1978). Seven of the patients had the endogenous 
subtype and 4 had distinct comorbid diagnoses, 
according to DSM-11 I-R: panic disorder with 
agoraphobia (3 p~ rients) and a combination of 
panic disorder with agoraphobia, obsessive 
compulsive disorder, and conduct diso~er (1 
patient), All adolescen,ts were depressea 
throughout an initial 2-6 wc~k medication-free 
assessment period. On the first w~k  of sleep 
studies, scores on the 17-item Hamilton Depres- 
sion Rating Scale (Hamilton 1960) ranged from 
11 to 27 with a mean of 19.0. 
The adolescents were studied poiysomno. 
graphically for two flairs of consecutive nights 
1 week apart. The studies we~ performed using 
an EFt3 sleep telephone telemetry system 
(TeleDiagaostic Systems, San Francisco) which 
enabled data to be telemetered from h~patients 
in their own ~:ds to ~h,e sleep laboratory control 
room. The studies were otherwise performed 
and ~malyz~ ~ described previously (Grunhaus 
et al. 1988). The patients were psychot-cpie 
medication-free on nlgtas ! and 2. Nights 3 and 
4 were the first two nights of treatment with 50 
mg of imipramine at 9:00 PM. Nights 1 and 3 
were considered adaptation n~ghts. Mem'~ values 
of selected sleep variables were compared ~ -  
tween night 2 (baseline) and night 4 (imipro. 
mille) with a two-tailed, paired t-test. 
R~;;~UIL3 
Sig.,,~fic~t REM suppressio~ was found ~_n hn- 
ipramine compared to baseline (Table 1). We 
found an increase in REM latency ~'p < 0.001) 
and decreases in REM time (p < 0.0001), REM 
percent (p < 0.0001), REM activity (F < 0.001), 
and ~mnber of REM periods (p < 0.0O01). REM 
density did not change significantly. Percent of 
stage 1 sleep increased (17 < 0.05), with no 
significant differences in percent _" stage 2 or 
delta sleep. No sleep continuity variables were 
significantly different, although increased num- 
ber of arousals showed a trend toward signifi- 
cance.  
Discuss ion 
Imipramine markedly suppressed REM sleep in 
depressed adolescents, and had only minor ef- 
fects on sleep continuity (a trend toward in- 
creased number of arousals) and sleep architec- 
ture (increased percent of stage 1 sleep). These 
findings were similar to those in depressed adults. 
2~-aztt et al. (1988) reported increased REM 
latency; decreased REM time, REM activity, 
REM density~ and number of REM periods; and 
no significant sleep continuity changes on the 
first night of treatment with imipramine. The 
sleep architect~.ue changes were different in adults: 
increased l:ercent of stag.. 2 sleep and no change 
in percent of stage 1 sleep 0arrett et al. 1988). 
Kupfer et al. (1979) found some similarities and 
differences in REM sleep in depressed chRdren 
who had been taking imipramine for 3 weeks. 
Similar:.'ties included increased REM latency, 
and decreased percent of REM and number of 
REM periods. Differences included not signif- 
icantly changed REM activity, and increased REaM 
density. There were als~ more imipramine=in- 
duced disturbances in sieep continuity and non- 
REM sleep architecture. The differences with 
the current findings', may have been due to the 
fact that sleep studies were done after 3 weeks 
of imipramine, rather than on night 2 of imi- 
pramine. 
The current findings suggest that effects of 
i.nipranfine on REM sleep in depressed adoles- 
cents are similar to effects on REM sleep in 
depressed adults. Further work is indicated, in- 
cluding investigations of the association be- 
tween antidepressam-induced changes in EEG- 
monitored sleep and eihfical response to the 
medication. 
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Table 1. Selected Sleep Variables 
Baseline 
Sleep variable Mean (SD) 
On imipramine 
Mean (sv) P p <  
Sleep continuity variables 
Total recording period (win) 427.5 (26.7) 
Sleep latency (min) 49.9 (30.8) 
Number of arousals 0.4 (0.7) 
Time spent asleep (min) 372.2 (50.2) 
Efficiency (TSAfrRP x 100) 86.9 (8.8) 
Sleep archi~ture 
Stage 1% 6.7 (4.2) 
Stage 2% 50.6 (4.7) 
Delta % 26.7 (7.2) 
REM % 16.1 (3.2) 
REM sleep variables 
REM latency (rain) 107.7 (42.9) 
REM tim ~, (min) 59.8 (14.2) 
REM activity (U) 61.4 (24.3) 
REM density ! O (0+4) 
No. of REM periods 3.5 (0.7) 
4"~9.3 (20.2) - 1.06 NS 
49.3 (35.2) 0.04 NS 
2.5 (2.5) -2.24 0.10 
373.~ (40.3) -0.13 NS 
85.1 (7.9) 0.58 NS 
14.8 (9.7) - 2.53 0.05 
54.0 (11.1) - 1.02 NS 
27.9 (9.0) - 0.81 NS 
3.3 (3.5) 9.56 0.0001 
312.6 (55.1) - 6 . 9 5  b 0.00! 
12.2 (13.2) 8.~3 0.0001 
8.7 (11.0) 5.64 0.001 
08 (0.2) I.~2 b NS 
0.7 (0.5) 9.64 0.0001 
+'rwo-tailed, paired t-test; df = 9 unless otherwise indicated. 
bNo REM sleep during 3 of the imipramine nights; df = 6. 
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